Jefferies Group XBI Holdings History
Jefferies Group's State Street SPDR S&P Biotech ETF Holding Summary
As of 2026-06-30, Leucadia National held 2.14 Mil shares of State Street SPDR S&P Biotech ETF(XBI), totaling $338.66 Mil. This investment constitutes 2.27% of their stock portfolio, and Leucadia National now holds 3.2% of the outstanding State Street SPDR S&P Biotech ETF(XBI) stock.
The initial trade took place in 2022Q4. And since then Jefferies Group has made 11 purchases of XBI, at an average price of $94.17, for a total of 3.91 Mil shares. In addition, there have been 4 sales at an average price of $87.00 for 1.77 Mil shares. Based on historical transaction data and XBI's current price of $159.38, Jefferies Group's estimated gain on his XBI holdings is $126.83 Mil, reflecting a 34.43% gain to date.
Jefferies Group XBI ($159.38) Holding Chart
Jefferies Group XBI ($159.38) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Articles on State Street SPDR S&P Biotech ETF
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
